v3.26.1
BALANCE SHEETS - USD ($)
Mar. 31, 2026
Mar. 31, 2025
Assets    
Cash and cash equivalents $ 8,846 $ 17,221
Deferred offering costs 0 222,095
Total Assets 8,846 239,316
Non-current asset    
Cash held in Trust Account 60,147,604 0
Total non-current Asset 60,147,604 0
Total Assets 60,156,450 239,316
Current Liabilities    
Accrued expenses 177,544 40,000
Promissory Note - Related party 313,401 337,584
Extension Payment Loan 450,000 0
Due to related parties 120,000 0
Total Current Liabilities 1,060,945 377,584
Commitments and Contingencies – (see Note 6) 0 0
Ordinary shares subject to possible redemption, 5,750,000 and nil shares issued and outstanding at redemption value of $10.46 and nil as of March 31, 2026 and 2025, respectively. 60,132,006 0
Shareholders’ Deficit    
Preference shares, $0.0001 par value; 10,000,000 shares authorized; nil and nil shares issued and outstanding as of March 31, 2026 and 2025, respectively. 0 0
Ordinary shares, $0.0001 par value; 490,000,000 shares authorized; 1,908,348 and 1,437,500 shares issued and outstanding (excluding 5,750,000 shares subject to redemption) as of March 31, 2026 and, 2025, respectively*. [1] 191 144
Additional paid-in capital 990,836 24,856
Accumulated deficit (2,027,528) (163,268)
Total Shareholders’ Deficit (1,036,501) (138,268)
Total Liabilities, Ordinary shares subject to possible redemption and Shareholders’ Deficit $ 60,156,450 $ 239,316
[1] Includes an aggregate of up to 187,500 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters as of March 31, 2025. As a result of the underwriter’s full exercise of its over-allotment option on April 7 and April 9, 2025, no Founder Shares are currently subject to forfeiture as of March 31, 2026. (see Note 5).